Shares of AstraZeneca (AZN) are lower as more headlines emerge on the scope of the ongoing China probe of the company’s China president, ...

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

Steven Goldstein is based in London and responsible for MarketWatch's coverage of financial markets in Europe, with a particular focus on global macro and commodities. Previously, he was ...

AstraZeneca disclosed Wednesday that Leon Wang, a high-ranking executive who oversees international operations and is also president of its subsidiary in China, is under investigation by Chinese ...

AstraZeneca (GB:AZN) has released an update. AstraZeneca PLC has announced its total issued share capital with voting rights stands at 1,550,303,887 ordinary shares as of October 31, 2024. This ...

Oct 7 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Monday it would pay up to $1.92 billion to CSPC Pharmaceutical Group Ltd (1093.HK), opens new tab in an exclusive licence agreement to ...

BEIJING—An investigation involving a top executive at drugmaker AstraZeneca AZN-0.18%decrease; red down pointing triangle is the latest to rattle foreign companies in China, where a series of ...

AstraZeneca (NASDAQ:AZN) is looking to boost its cardiovascular pipeline through an exclusive license agreement with CSPC Pharmaceutical Group (CSPC). As part of the deal, AstraZeneca will pay $ ...

The president of AstraZeneca’s China division has been placed under investigation by local police, as Beijing advances an anti-corruption crackdown in the healthcare sector. The British ...

AstraZeneca has paid CSPC Pharmaceutical Group $100 million for a preclinical cardiovascular disease drug. The deal, which covers a potential rival to an Eli Lilly prospect, positions AstraZeneca ...

AstraZeneca, the UK’s largest drugmaker valued ... It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or ...